Recent News
On January 9, 2026 Haemonetics announced acquisition of Vivasure Medical Limited, adding the PerQseal Elite bioabsorbable large-bore vessel-closure technology to its portfolio. Follow-on coverage in mid-January reported the deal structure and expected cash timing to the seller, including upfront and milestone components. Recent company slide releases and summaries through February highlighted margin expansion, elevated free cash flow guidance, and a planned settlement strategy for March convertible notes using cash and the existing credit facility.
Technical Analysis
Directional indicators show a strong trend: ADX at 34.89 indicates trend strength, while DI+ rising and DI- falling signal bullish directional pressure that supports a near-term positive price bias relative to valuation.
MACD sits at -2.95 with the MACD line above the signal (-3.56); the crossover and the MACD trend increasing point to a shift toward bullish momentum despite negative absolute MACD, reinforcing short-term upside potential tied to the company’s under-valued status.
The MRO reads -13.03 and is increasing, which indicates price currently sits below WMDST’s target and therefore carries upward pressure; the magnitude suggests a measurable—but not extreme—bias toward a corrective rise toward target levels.
RSI at 42.04 and rising shows building buying pressure without overbought conditions; this supports potential continuation of the short-term recovery while leaving room before momentum exhaustion.
Price sits at $62.34, above the 20-day average ($60.06) and the 12-day EMA which recently completed a dip-and-reversal, but remains below the 50-day ($71.53) and 200-day ($66.21) averages—placing immediate resistance at the longer-term averages. The price trades near the upper Bollinger band (upper 1σ $62.51), suggesting intraday compression ahead of a directional resolution. SuperTrend upper at $62.85 sits just above current price and may act as near-term overhead resistance; Ichimoku components place price above the Tenkan (61.79) but below the Kijun (66.03), a configuration consistent with short-term strength within longer-term resistance.
Fundamental Analysis
Total revenue reached $338,967,000, with gross margin at 59.71% and operating margin at 20.09%, supporting the observed expansion in operating profitability. EBIT of $67,396,000 yields an EBIT margin of 19.88%, which improves QoQ by 11.27% and YoY by 17.40%, but sits below the industry peer mean (25.48%) and median (26.12%).
Earnings per share came in at $0.95 versus an estimate of $0.90, an EPS surprise of $0.05 or +5.56%, recorded on the most recent report dated 2026-02-05. Operating cash flow of $93,564,000 and free cash flow of $87,215,000 produce a free cash flow yield of 2.59%, above the industry peer mean of 0.84%, supporting valuation resilience despite elevated leverage.
Balance-sheet and leverage highlight trade-offs: cash and short-term investments total $363,367,000 while net debt sits at $861,366,000. Debt to assets equals 49.17%, above the industry peer mean (32.82%) and median (33.15%), and debt to EBITDA reads 12.92x—elevated versus typical peer levels—while interest coverage measures 9.08x. These metrics show ample interest-service capacity but materially more leverage than peers.
Valuation multiples present a mixed signal. Price-to-book at 3.70 sits below the industry peer mean (7.65) and median (6.17). Price-to-earnings at 54.99 compares below the industry peer mean (141.82) and below the industry peer median (68.23). Enterprise multiple at 44.68 and forward metrics point to premium expectations for future earnings, yet WMDST’s current assessment classifies the stock as under-valued given margin expansion, cash generation, and the recent strategic acquisition bolstering product breadth.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-02-05 |
| NEXT REPORT DATE: | 2026-05-07 |
| CASH FLOW | Begin Period Cash Flow | $ 296.4 M |
| Operating Cash Flow | $ 93.6 M | |
| Capital Expenditures | $ -6.35 M | |
| Change In Working Capital | $ 11.8 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 66.9 M | |
| End Period Cash Flow | $ 363.4 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 339.0 M | |
| Forward Revenue | $ 118.0 M | |
| COSTS | ||
| Cost Of Revenue | $ 136.6 M | |
| Depreciation | $ 16.5 M | |
| Depreciation and Amortization | $ 27.4 M | |
| Research and Development | $ 14.2 M | |
| Total Operating Expenses | $ 270.9 M | |
| PROFITABILITY | ||
| Gross Profit | $ 202.4 M | |
| EBITDA | $ 94.8 M | |
| EBIT | $ 67.4 M | |
| Operating Income | $ 68.1 M | |
| Interest Income | — | |
| Interest Expense | $ 7.4 M | |
| Net Interest Income | $ -7.42 M | |
| Income Before Tax | $ 60.0 M | |
| Tax Provision | $ 15.2 M | |
| Tax Rate | 25.402 % | |
| Net Income | $ 44.7 M | |
| Net Income From Continuing Operations | $ 44.7 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.90 | |
| EPS Actual | $ 0.95 | |
| EPS Difference | $ 0.05 | |
| EPS Surprise | 5.556 % | |
| Forward EPS | $ 1.33 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 2.5 B | |
| Intangible Assets | $ 1.0 B | |
| Net Tangible Assets | $ -115.11 M | |
| Total Current Assets | $ 943.7 M | |
| Cash and Short-Term Investments | $ 363.4 M | |
| Cash | $ 363.4 M | |
| Net Receivables | $ 195.7 M | |
| Inventory | $ 321.2 M | |
| Long-Term Investments | $ 216.1 M | |
| LIABILITIES | ||
| Accounts Payable | $ 48.7 M | |
| Short-Term Debt | $ 304.7 M | |
| Total Current Liabilities | $ 539.9 M | |
| Net Debt | $ 861.4 M | |
| Total Debt | $ 1.2 B | |
| Total Liabilities | $ 1.6 B | |
| EQUITY | ||
| Total Equity | $ 911.5 M | |
| Retained Earnings | $ 381.1 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 19.46 | |
| Shares Outstanding | 46.829 M | |
| Revenue Per-Share | $ 7.24 | |
| VALUATION | Market Capitalization | $ 3.4 B |
| Enterprise Value | $ 4.2 B | |
| Enterprise Multiple | 44.677 | |
| Enterprise Multiple QoQ | 12.694 % | |
| Enterprise Multiple YoY | 11.191 % | |
| Enterprise Multiple IPRWA | high: 68.596 median: 68.596 mean: 65.07 HAE: 44.677 low: -16.761 |
|
| EV/R | 12.492 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 2.733 | |
| Asset To Liability | 1.577 | |
| Debt To Capital | 0.573 | |
| Debt To Assets | 0.492 | |
| Debt To Assets QoQ | -1.956 % | |
| Debt To Assets YoY | 24484.0 % | |
| Debt To Assets IPRWA | high: 0.642 HAE: 0.492 median: 0.331 mean: 0.328 low: 0.011 |
|
| Debt To Equity | 1.344 | |
| Debt To Equity QoQ | -6.832 % | |
| Debt To Equity YoY | 23895.0 % | |
| Debt To Equity IPRWA | high: 2.909 HAE: 1.344 median: 0.707 mean: 0.694 low: 0.012 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 3.701 | |
| Price To Book QoQ | 25.171 % | |
| Price To Book YoY | -12.913 % | |
| Price To Book IPRWA | high: 10.911 mean: 7.646 median: 6.173 HAE: 3.701 low: 0.61 |
|
| Price To Earnings (P/E) | 54.985 | |
| Price To Earnings QoQ | 30.021 % | |
| Price To Earnings YoY | -14.708 % | |
| Price To Earnings IPRWA | high: 252.809 mean: 141.825 median: 68.23 HAE: 54.985 low: -23.452 |
|
| PE/G Ratio | 17.456 | |
| Price To Sales (P/S) | 9.951 | |
| Price To Sales QoQ | 29.733 % | |
| Price To Sales YoY | -10.0 % | |
| Price To Sales IPRWA | high: 19.3 median: 19.3 mean: 16.331 HAE: 9.951 low: 0.541 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 53.918 | |
| Forward PE/G | 17.117 | |
| Forward P/S | 28.584 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | 4.277 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.137 | |
| Asset Turnover Ratio QoQ | 2.959 % | |
| Asset Turnover Ratio YoY | -0.312 % | |
| Asset Turnover Ratio IPRWA | high: 0.371 median: 0.144 mean: 0.14 HAE: 0.137 low: 0.065 |
|
| Receivables Turnover | 1.683 | |
| Receivables Turnover Ratio QoQ | 4.857 % | |
| Receivables Turnover Ratio YoY | 2.736 % | |
| Receivables Turnover Ratio IPRWA | high: 2.545 mean: 2.011 median: 1.909 HAE: 1.683 low: 0.741 |
|
| Inventory Turnover | 0.416 | |
| Inventory Turnover Ratio QoQ | 9.189 % | |
| Inventory Turnover Ratio YoY | -0.577 % | |
| Inventory Turnover Ratio IPRWA | high: 1.175 mean: 0.547 median: 0.531 HAE: 0.416 low: 0.186 |
|
| Days Sales Outstanding (DSO) | 54.213 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 242.468 | |
| Cash Conversion Cycle Days QoQ | -8.48 % | |
| Cash Conversion Cycle Days YoY | 4.687 % | |
| Cash Conversion Cycle Days IPRWA | high: 433.862 HAE: 242.468 median: 201.642 mean: 197.59 low: -2.143 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 0.839 | |
| CapEx To Revenue | -0.019 | |
| CapEx To Depreciation | -0.386 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 1.8 B | |
| Net Invested Capital | $ 2.1 B | |
| Invested Capital | $ 2.1 B | |
| Net Tangible Assets | $ -115.11 M | |
| Net Working Capital | $ 403.8 M | |
| LIQUIDITY | ||
| Cash Ratio | 0.673 | |
| Current Ratio | 1.748 | |
| Current Ratio QoQ | 6.532 % | |
| Current Ratio YoY | -55.994 % | |
| Current Ratio IPRWA | high: 10.0 median: 4.04 mean: 3.318 HAE: 1.748 low: 0.771 |
|
| Quick Ratio | 1.153 | |
| Quick Ratio QoQ | 12.203 % | |
| Quick Ratio YoY | -54.818 % | |
| Quick Ratio IPRWA | high: 9.809 median: 3.316 mean: 2.549 HAE: 1.153 low: 0.437 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 12.922 | |
| Cost Of Debt | 0.452 % | |
| Interest Coverage Ratio | 9.082 | |
| Interest Coverage Ratio QoQ | 11.886 % | |
| Interest Coverage Ratio YoY | 40.191 % | |
| Interest Coverage Ratio IPRWA | high: 413.451 median: 30.115 mean: 28.968 HAE: 9.082 low: -7.547 |
|
| Operating Cash Flow Ratio | 0.158 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 37.99 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 1.996 % | |
| Revenue Growth | 3.56 % | |
| Revenue Growth QoQ | 93.268 % | |
| Revenue Growth YoY | 305.929 % | |
| Revenue Growth IPRWA | high: 20.682 % median: 14.415 % mean: 11.67 % HAE: 3.56 % low: -10.847 % |
|
| Earnings Growth | 3.15 % | |
| Earnings Growth QoQ | -79.618 % | |
| Earnings Growth YoY | -49.6 % | |
| Earnings Growth IPRWA | high: 500.0 % mean: 14.566 % median: 5.417 % HAE: 3.15 % low: -48.649 % |
|
| MARGINS | ||
| Gross Margin | 59.707 % | |
| Gross Margin QoQ | 0.353 % | |
| Gross Margin YoY | 7.522 % | |
| Gross Margin IPRWA | high: 86.595 % median: 64.538 % mean: 62.59 % HAE: 59.707 % low: 13.674 % |
|
| EBIT Margin | 19.883 % | |
| EBIT Margin QoQ | 11.265 % | |
| EBIT Margin YoY | 17.401 % | |
| EBIT Margin IPRWA | high: 30.155 % median: 26.119 % mean: 25.476 % HAE: 19.883 % low: -65.676 % |
|
| Return On Sales (ROS) | 20.094 % | |
| Return On Sales QoQ | -1.942 % | |
| Return On Sales YoY | 18.647 % | |
| Return On Sales IPRWA | high: 30.155 % mean: 25.493 % median: 25.254 % HAE: 20.094 % low: -4.912 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 87.2 M | |
| Free Cash Flow Yield | 2.586 % | |
| Free Cash Flow Yield QoQ | -38.923 % | |
| Free Cash Flow Yield YoY | 182.932 % | |
| Free Cash Flow Yield IPRWA | high: 4.073 % HAE: 2.586 % median: 0.969 % mean: 0.841 % low: -5.003 % |
|
| Free Cash Growth | -17.958 % | |
| Free Cash Growth QoQ | -102.644 % | |
| Free Cash Growth YoY | 69.639 % | |
| Free Cash Growth IPRWA | high: 152.763 % mean: 4.861 % median: -0.761 % HAE: -17.958 % low: -446.345 % |
|
| Free Cash To Net Income | 1.949 | |
| Cash Flow Margin | 25.226 % | |
| Cash Flow To Earnings | 1.911 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 1.814 % | |
| Return On Assets QoQ | 14.956 % | |
| Return On Assets YoY | 22.32 % | |
| Return On Assets IPRWA | high: 15.87 % mean: 2.747 % median: 1.969 % HAE: 1.814 % low: -11.044 % |
|
| Return On Capital Employed (ROCE) | 3.454 % | |
| Return On Equity (ROE) | 0.049 | |
| Return On Equity QoQ | 7.772 % | |
| Return On Equity YoY | 18.747 % | |
| Return On Equity IPRWA | high: 0.174 HAE: 0.049 mean: 0.038 median: 0.038 low: -0.428 |
|
| DuPont ROE | 5.082 % | |
| Return On Invested Capital (ROIC) | 2.354 % | |
| Return On Invested Capital QoQ | 10.672 % | |
| Return On Invested Capital YoY | -116.768 % | |
| Return On Invested Capital IPRWA | high: 5.899 % median: 3.865 % mean: 3.509 % HAE: 2.354 % low: -1.411 % |
|